Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8